Catalyst Wire Dossier Catalyst Wire Dossier

elenbecestat

elenbecestat · Eisai Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for elenbecestat, covering 2021-02-03 to 2021-02-03. Get the full timeline:

Most recent: Clinical Trial Update: A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's Disease [Phase 3]

See pricing